[Treatment of primary bone lymphomas].
Primary bone lymphoma constitutes a rare entity. They are often localized. The studies published are retrospective, using definitions and different classifications. The populations of the studied patients are often heterogeneous. The therapeutic modalities used are also different. Consequently, the prognostic stratification and the analysis of the therapeutic results are difficult. We review the literature and discuss the therapeutic modalities and the results as well as the prognosis of the primary bone lymphomas.
Service de radiothérapie, CHU Habib-Bourguiba, 3029 Sfax, Tunisie; Faculté de médecine, université de Sfax, 3029 Sfax, Tunisie. Electronic address: ben_salah_hanen@yahoo.fr.
H
H
Ben Salah
N
N
Ajmi
M
M
Elloumi
J
J
Daoud
D001859:Bone Neoplasms / Q000473:pathology / Q000628:therapy*; D059248:Chemoradiotherapy; D006801:Humans; D008223:Lymphoma / Q000473:pathology / Q000628:therapy*; D009367:Neoplasm Staging; D011379:Prognosis; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D016019:Survival Analysis
Chemotherapy; Chimiothérapie; Lymphomes osseux primitifs; Primary bone lymphomas; Radiotherapy; Radiothérapie; Traitement; Treatment